GSH and GABA decreases in IDH1-mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo

T Gong, X Zhang, X Wei, S Yuan, MG Saleh… - Neurochemistry …, 2020 - Elsevier
Abstract Isocitrate dehydrogenase 1 (IDH1) mutational status is an important prognostic
biomarker in gliomas. γ-aminobutyric acid (GABA) and reduced glutathione (GSH) play an …
被引用次数：7 相关文章

GSH and GABA decreases in IDH1-mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo

T Gong, X Zhang, X Wei, S Yuan… - Neurochemistry …, 2020 - pure.johnshopkins.edu
Abstract Isocitrate dehydrogenase 1 (IDH1) mutational status is an important prognostic
biomarker in gliomas. γ-aminobutyric acid (GABA) and reduced glutathione (GSH) play an …

GSH and GABA decreases in IDH1-mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo.

T Gong, X Zhang, X Wei, S Yuan, MG Saleh… - Neurochemistry …, 2020 - europepmc.org
Abstract Isocitrate dehydrogenase 1 (IDH1) mutational status is an important prognostic
biomarker in gliomas. γ-aminobutyric acid (GABA) and reduced glutathione (GSH) play an …

GSH and GABA decreases in IDH1-mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo

T Gong, X Zhang, X Wei, S Yuan… - Neurochemistry …, 2020 - pubmed.ncbi.nlm.nih.gov
Isocitrate dehydrogenase 1 (IDH1) mutational status is an important prognostic biomarker in
gliomas. γ-aminobutyric acid (GABA) and reduced glutathione (GSH) play an important role …

GSH and GABA decreases in IDH1 mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo

T Gong, R Edden, G Wang - archive.ismrm.org
IDH1 mutation could result in better prognosis compared with wild-type, but the mechanisms
remain largely unknown. GABA and GSH are low-concentration metabolites, could not be …
[HTML] nih.gov

[HTML][HTML] GSH and GABA decreases in IDH1-mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo

T Gong, X Zhang, X Wei, S Yuan… - Neurochemistry …, 2020 - ncbi.nlm.nih.gov
Abstract Isocitrate dehydrogenase 1 (IDH1) mutational status is an important prognostic
biomarker in gliomas. γ-aminobutyric acid (GABA) and reduced glutathione (GSH) play an …